Effects of verapamil and trandolapril in the treatment of hypertension

American Journal of Hypertension

Volumn 11, Issue 3 I, 1998, Pages 322-327

  Messerli, Franz ^a   Frishman, William H ^b   Elliott, William J ^c  

^a OCHSNER MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Calcium antagonists; Combination therapy; Drug effects; Side effects

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; TRANDOLAPRIL; VERAPAMIL;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SINGLE BLIND PROCEDURE; THORAX PAIN; VERTIGO;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; HYPERTENSION; INDOLES; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VERAPAMIL;

EID: 0031966414     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00466-4     Document Type: Article

References (14)

1. Joint National Committee: The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993;153:154-183.
2. Chobanian AV: Antihypertensive therapy in evolution. N Engl J Med 1986;314:1701-1702.
3. Messerli FH: Combination antihypertensive therapy, in Messerli FH (ed): The ABC's of Antihypertensive Therapy. New York, Raven Press, 1994, pp 247-260.
4. Frishman WH, Ram CVS, McMahon FG, et al: Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/ Amlodipine Study Groups. J Clin Pharmacol 1995;35: 1060-1066.
5. Salvetti A, Innocenti PF, Iardella M, et al: Captopril and nifedipine interactions in the treatment of essential hypertensives: a crossover study. J Hypertens 1987; 5(suppl 4):S139-S142.
6. Singer DR, Markandu ND, Shore AC, MacGregor GA: Captopril and nifedipine in combination for moderate to severe essential hypertension. Hypertension 1987;9: 629-633.
7. Steiner G, Pauly NC, for the Investigator Study Group: Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. J Cardiovasc Pharmacol 1994;23:S81-S85.
8. Kaplan NM: Antihypertensive therapy to maximally reduce coronary risk. Am Heart J 1993;125:1487-1493.
9. Lenfant B, Mouren M, Bryce T, et al: Trandolapril: pharmacokinetics of single oral doses in healthy male volunteers. J Cardiovasc Pharmacol 1994;23(suppl 4): S38-S43.
10. Guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989;7:689-693.
11. MacGregor GA, Markandu ND, Smith SJ, Sagnella GA: Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol 1985;7:S82-S87.
12. Frishman WH, Landau A, Cretkovic A: Combination drug therapy with calcium-channel blockers in the treatment of systemic hypertension. J Clin Pharmacol 1993;33:752-755.
13. Helgeland A, Strommen R, Hagelund CH, Tretli S: Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway. Lancet 1986;872-875.
14. Division of Cardio-Renal Drugs Products, Food and Drug Administration: Proposed Guidelines for the Clinical Evaluation of Antihypertensive Drugs. US Department of Health and Human Services, Rockville, MD, 1988.